Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontier
Go back to Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontier| (NASDAQ: ANIX) | Delayed: 2.73 +0.03 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.70 | 52 Week High | $ | |||
| Open | $2.73 | 52 Week Low | $ | |||
| Day High | $2.75 | P/E | N/A | |||
| Day Low | $2.68 | EPS | $ | |||
| Volume | 71,984 | |||||
